Original Article

You have full text access to this OnlineOpen article

Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia

  1. James A. Taylor MD†,*,
  2. Laura Winter PharmD,
  3. Leah J. Geyer AB,
  4. Douglas S. Hawkins MD

Article first published online: 14 AUG 2006

DOI: 10.1002/cncr.22131

Issue

Cancer

Cancer

Volume 107, Issue 6, pages 1400–1406, 15 September 2006

Additional Information

How to Cite

Taylor, J. A., Winter, L., Geyer, L. J. and Hawkins, D. S. (2006), Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer, 107: 1400–1406. doi: 10.1002/cncr.22131

Author Information

  1. Department of Pediatrics, University of Washington and Children's Hospital and Regional Medical Center, Seattle, Washington

  1. †

    Fax: (206) 616-4623

*Department of Pediatrics, University of Washington Child Health Institute, Box 354920, Seattle, WA 98195

Publication History

  1. Issue published online: 1 SEP 2006
  2. Article first published online: 14 AUG 2006
  3. Manuscript Accepted: 15 JUN 2006
  4. Manuscript Revised: 25 MAY 2006
  5. Manuscript Received: 31 MAR 2006

Funded by

  • Children's Hospital and Regional Medical Center, Seattle, WA

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (126K)

REFERENCES

  • 1
    KohnLT, DonaldsonMS, eds. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
  • 2
    Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991; 324: 370–376.
  • 3
    Thomas EJ, Studdert DM, Burstin HR. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000; 38: 261–271.
  • 4
    Boyle DA, Schulmeister L, Lajeunesse JD, Anderson RW. Medication misadventures in cancer care. Semin Oncol Nurs. 2002; 18: 109–120.
  • 5
    Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285: 2114–2120.
  • 6
    Gandhi TK, Bartel SB, Shulman LN, et al. Medication safety in the ambulatory chemotherapy setting. Cancer. 2005; 104: 2477–2483.
    Direct Link:
  • 7
    Gandhi TK, Weingart SN, Seger AC, et al. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med. 2005; 20: 837–841.
    Direct Link:
  • 8
    McPhillips HA, Stille CJ, Smith D, et al. Potential medication dosing errors in outpatient pediatrics. J Pediatr. 2005; 147: 761–767.
  • 9
    Barker KN, Flynn EA, Pepper GA, Bates DW, Mikeal RL. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002; 162: 1897–1903.
  • 10
    Hanley JA. Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983; 249: 1743–1745.
  • 11
    Flynn EA, Barker KN, Gibson T, Pearson RE, Berger BA, Smith LA. Impact of interruptions and distractions on dispensing errors in an ambulatory pharmacy. Am J Health Syst Pharm. 1999; 56: 1319–1325.
  • 12
    Kistner UA, Keith MR, Sargeant KA, Hokanson JA. Accuracy of dispensing in a high-volume, hospital-based outpatient pharmacy. Am J Hosp Pharm. 1994; 51; 2793–2797.
  • 13
    Leape LL, Woods DD, Hatlie MJ, Kizer KW, Schroeder SA, Lundberg GD. Promoting patient safety by preventing medical error. JAMA. 1998; 280: 1444–1447.
  • 14
    Kaushal R, Barker KN, Bates DW. How can information technology improve patient safety and reduce medication errors in children's health care? Arch Pediatr Adolesc Med. 2001; 155: 1002–1007.
  • 15
    Smith SD, Rosen D, Trueworthy RC, Lowman JT. A reliable method for evaluating drug compliance in children with cancer. Cancer. 1979; 43: 169–173.
    Direct Link:
  • 16
    Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer. 1986; 58: 1179–1184.
    Direct Link:
  • 17
    Lennard L, Welch J, Lilleyman JS. Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? Br J Cancer. 1995; 72: 1004–1006.
  • 18
    Macdougall LG, McElligott SE, Ross E, Greeff MC, Poole JE. Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance. Ther Drug Monit. 1992; 14: 371–375.
View Full Article (HTML) Get PDF (126K)